A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients

This study has been completed.
Information provided by NIH AIDS Clinical Trials Information Service

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Herpes Simplex
			HIV Infections
2		Additional conditions recognized in this trial
			Acquired Immunodeficiency Syndrome
			Communicable Diseases
			Herpesviridae Infections
			Infection
3		More general conditions related to this trial
			DNA Virus Infections
			Immune System Diseases
			Immunologic Deficiency Syndromes
			Lentivirus Infections
			Retroviridae Infections
			RNA Virus Infections
			Sexually Transmitted Diseases
			Sexually Transmitted Diseases, Viral
			Skin Diseases
			Skin Diseases, Infectious
			Skin Diseases, Viral
			Slow Virus Diseases
			Virus Diseases
4		Interventions listed in this trial
			Valacyclovir hydrochloride
			Acyclovir
5		Additional drug interventions recognized in this trial
			Valacyclovir
6		More general drug interventions related to this trial
			Anti-Infective Agents
			Antiviral Agents
			Pharmacologic Actions
			Therapeutic Uses
7		Sponsors listed in this trial
			Glaxo Wellcome